Stories
Slash Boxes
Comments

SoylentNews is people

posted by takyon on Tuesday January 29 2019, @08:00PM   Printer-friendly
from the remove-brain dept.

It May be Possible to Restore Memory Function in Alzheimer's, Preclinical Study Finds

Submitted via IRC for Bytram

It may be possible to restore memory function in Alzheimer's, preclinical study finds

Research published today (Jan. 22) in the journal Brain reveals a new approach to Alzheimer's disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.

The team, led by University at Buffalo scientists, found that by focusing on gene changes caused by influences other than DNA sequences -- called epigenetics -- it was possible to reverse memory decline in an animal model of AD.

"In this paper, we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of AD," said senior author Zhen Yan, PhD, a SUNY Distinguished Professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB.

The research was conducted on mouse models carrying gene mutations for familial AD -- where more than one member of a family has the disease -- and on post-mortem brain tissues from AD patients.

Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease (open, DOI: 10.1093/brain/awy354) (DX)

Early Prediction of Alzheimer's Progression: Blood Protein

Submitted via IRC for Bytram

Early prediction of Alzheimer's progression: Blood protein

Years before symptoms of Alzheimer's disease manifest, the brain starts changing and neurons are slowly degraded. Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tuebingen now show that a protein found in the blood can be used to precisely monitor disease progression long before first clinical signs appear. This blood marker offers new possibilities for testing therapies. The study was carried out in cooperation with an international research team and published in the journal Nature Medicine.

"The fact that there is still no effective treatment for Alzheimer's is partly because current therapies start much too late," says Mathias Jucker, a senior researcher at the DZNE's Tuebingen site and at the HIH. He headed the current study. In order to develop better treatments, scientists therefore need reliable methods to monitor and predict the course of the disease before symptoms such as memory changes occur. A blood test is better suited for this than e. g. expensive brain scans.

Recently, there was some progress in the development of such blood tests. Most of them are based on so-called amyloid proteins. In Alzheimer's disease, amyloid proteins accumulate in the brain and also occur in the blood. However, Jucker and his colleagues take a different approach. "Our blood test does not look at the amyloid, but at what it does in the brain, namely neurodegeneration. In other words, we look at the death of neurons," says Jucker.

Note: DZNE is: "Deutsches Zentrum für Neurodegenerative Erkrankungen".

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's Disease (DOI: 10.1038/s41591-018-0304-3) (DX)


Original Submission #1Original Submission #2

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.